Join the Breast Cancer group to help and get support from people like you.
Breast Cancer News (Page 6)
Related terms: Breast Cancer, inflammatory, Cancer, Breast, Carcinoma, Ductal, Carcinoma, Lobular, Ductal Carcinoma in Situ (DCIS), Ductal Carcinoma in Situ, DCIS
Screening Primary Driver of Averted Cancer Deaths From 1975 to 2020
TUESDAY, Dec. 10, 2024 – Over the past 45 years, cancer prevention and screening accounted for most cancer deaths averted for breast, cervical, colorectal, lung, and prostate cancers, according to a...
Adding Previous Screening Mammogram Images Improves Cancer Prediction
MONDAY, Dec. 9, 2024 – Five-year breast cancer (BC) risk prediction is improved with the addition of previous screening mammogram images beyond static models, according to a study published online...
AI Reads Multiple Mammograms to Help Predict Breast Cancer Risk
FRIDAY, Dec. 6, 2024 – A new AI can help identify women at higher risk for developing breast cancer by tracking changes in breast tissue, a new study shows. The AI compares women’s own mammograms o...
Prevention Outpaced Treatment Advances in Saving Lives From Major Cancers
THURSDAY, Dec. 5, 2024 – “An ounce of prevention is worth a pound of cure,” founding father Benjamin Franklin once said. That’s definitely true of cancer, a new study has found. Cancer prevention and...
New Therapeutic Vaccine Gives Hope Against an Aggressive Breast Cancer
THURSDAY, Nov. 14, 2024 – An experimental vaccine could offer fresh hope to women diagnosed with an aggressive and hard-to-treat form of breast cancer, new research suggests. The vaccine appears to...
Neoantigen DNA Vaccines Safe, Induce Response in Triple-Negative Breast Cancer
THURSDAY, Nov. 14, 2024 – Neoantigen DNA vaccines are safe and capable of inducing neoantigen-specific immune responses in patients with triple-negative breast cancer, according to a study published...
Inavolisib + Palbociclib-Fulvestrant Improves Survival in Advanced Breast Cancer
THURSDAY, Oct. 31, 2024 – Inavolisib plus palbociclib-fulvestrant yields significantly longer progression-free survival than placebo plus palbociclib-fulvestrant in patients with PIK3CA-mutated,...
Lack of Insurance Could Mean Later Cancer Diagnoses for Black, Hispanic Americans
WEDNESDAY, Oct. 30, 2024 – A lack of health insurance coverage raises the risk that cancers among Black and Hispanic Americans will be caught too late, a new study suggests. Being uninsured accounts...
Multigene Signature Can Help Tailor Chemo for Operable Triple-Negative Breast Cancer
WEDNESDAY, Oct. 30, 2024 – For patients with operative triple-negative breast cancer, a multigene signature can help tailor adjuvant chemotherapy, according to a study published online Oct. 23 in...
Guideline-Concordant Care Less Likely With Non-Hispanic Black Race
TUESDAY, Oct. 29, 2024 – For older patients with breast cancer, non-Hispanic Black race is associated with increased odds of not receiving guideline-concordant care (GCC) and less timely initiation...
Medicaid Expansion Increases Guideline-Concordant Treatment for Breast Cancer
FRIDAY, Oct. 25, 2024 – Expanding Medicaid is associated with an increase in receipt of guideline-concordant treatment among nonelderly women newly diagnosed with hormone receptor (HR)-negative,...
Aerobic Exercise May Ease 'Brain Fog' of Breast Cancer Chemo
WEDNESDAY, Oct. 23, 2024 – Women fighting breast cancer can relieve some of their chemotherapy “brain fog” through aerobic exercise, a new clinical trial in Canada suggests. Breast cancer patients on...
Measures of Social Support Linked to Cancer Screening
MONDAY, Oct. 21, 2024 – Measures of social support are associated with screening for specific types of cancer, according to a study published online Oct. 18 in Cancer Causes & Control. Jordan Baeker...
Family, Friends Crucial to Whether You Get Screened for Cancer
FRIDAY, Oct. 18, 2024 – Having close family and friends who care about their health makes women more likely to get regularly screened for cancer, a new study has found. Women are more likely to...
Breast Cancer Risk Elevated With Levonorgestrel-Releasing Intrauterine System Use
FRIDAY, Oct. 18, 2024 – Women using levonorgestrel-releasing intrauterine systems (LNG-IUS) have an increased risk for breast cancer, according to a study published online Oct. 16 in the Journal of...
Further information
Related condition support groups
Breast Cancer, Metastatic, Breast Cancer - Adjuvant, Breast Cancer - Male, Cancer
Related drug support groups
methotrexate, fluorouracil, anastrozole, letrozole, Arimidex, Herceptin, Keytruda, Femara, tamoxifen, trastuzumab, Ibrance